As of May 26
| -0.15 / -2.01%|
The 2 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 4.25, with a high estimate of 6.50 and a low estimate of 2.00. The median estimate represents a -42.02% decrease from the last price of 7.33.
The current consensus among 2 polled investment analysts is to Hold stock in Rockwell Medical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.